Page last updated: 2024-08-25

3-deazaneplanocin and aristeromycin

3-deazaneplanocin has been researched along with aristeromycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Clercq, E1
De Clercq, E; González, M; Jashés, M; López-Lastra, M; Sandino, A1
Kawamoto, T; Tanaka, Y; Uchiyama, N1

Reviews

1 review(s) available for 3-deazaneplanocin and aristeromycin

ArticleYear
S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents.
    Biochemical pharmacology, 1987, Aug-15, Volume: 36, Issue:16

    Topics: Adenosine; Adenosylhomocysteinase; Animals; Antiviral Agents; Hydrolases; Models, Biological; Tubercidin; Virus Replication

1987

Other Studies

2 other study(ies) available for 3-deazaneplanocin and aristeromycin

ArticleYear
Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Antiviral research, 1996, Volume: 29, Issue:2-3

    Topics: Adenosine; Adenosylhomocysteinase; Amides; Animals; Antiviral Agents; Cell Line; DNA; Foscarnet; Hydrolases; IMP Dehydrogenase; Infectious pancreatic necrosis virus; Orotidine-5'-Phosphate Decarboxylase; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Salmon; Viral Plaque Assay; Virus Replication

1996
Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
    European journal of pharmacology, 2017, Oct-05, Volume: 812

    Topics: Adenosine; Adenosylhomocysteinase; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; MicroRNAs; Prostatic Neoplasms; RNA, Small Interfering; Transcriptional Activation

2017